Avanos Medical Inc. (AVNS)
undefined
undefined%
At close: undefined
17.97
-0.17%
After-hours Dec 13, 2024, 07:00 PM EST

Company Description

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.

The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.

It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.

The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.

Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical Inc.
Avanos Medical Inc. logo
Country United States
IPO Date Oct 21, 2014
Industry Medical - Devices
Sector Healthcare
Employees 3,771
CEO Michael C. Greiner CPA

Contact Details

Address:
5405 Windward Parkway
Alpharetta, Georgia
United States
Website https://avanos.com

Stock Details

Ticker Symbol AVNS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001606498
CUSIP Number 05350V106
ISIN Number US05350V1061
Employer ID 46-4987888
SIC Code 3842

Key Executives

Name Position
Kerr W. Holbrook Senior Vice President & Chief Commercial Officer
Mojirade James Senior Vice President, General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
Dec 05, 2024 4 Filing
Dec 03, 2024 8-K Current Report
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 06, 2024 3 Filing
Nov 04, 2024 8-K Current Report
Oct 31, 2024 4 Filing
Oct 30, 2024 10-Q Quarterly Report
Oct 30, 2024 8-K Current Report
Sep 09, 2024 4 Filing
Jul 31, 2024 10-Q Quarterly Report